YAMAGUCHI UNIVERSITY Patent applications |
Patent application number | Title | Published |
20150376119 | THICKENING STABILIZER, AND THICKENING/STABILIZING COMPOSITION USING THE SAME - Provided is a compound which thickens or gels a fluid organic material to a desired viscosity, or which uniformly stabilizes the formulation of a composition containing the fluid organic material. | 12-31-2015 |
20150299647 | MEDIUM FOR YEASTS - In order to provide a culture medium eliminating variation by lot of component concentrations, the present invention provides a culture medium, and preferably a chemical-synthetic culture medium, imparting a proliferation ability to yeast that is equivalent to or greater than that of a YPD culture medium. A culture medium is provided which includes sugars as a carbon source capable of being assimilated by yeast; amino acids as a nitrogen source; vitamins; inositol; zinc ion (Zn | 10-22-2015 |
20150291452 | ION EXCHANGE MEMBRANE, METHOD FOR PRODUCING SAME, AND ELECTRODIALYZER - Provided is an ion exchange membrane including an ionic vinyl alcohol polymer having a cation exchange group or an anion exchange group. The ion exchange membrane | 10-15-2015 |
20150290172 | THERAPEUTIC AGENT FOR KERATOCONJUNCTIVE DISORDERS - The present invention addresses the problem of providing a novel therapeutic agent for keratoconjunctive disorders. As a means for solving the problem, a therapeutic agent for keratoconjunctive disorders which contains a RARγ agonist as an active ingredient is provided. The therapeutic agent exhibits an excellent ameliorating effect in a keratoconjunctive disorder model, and is therefore useful as a therapeutic agent for keratoconjunctive disorders such as corneal ulcer, corneal epithelial abrasion, keratitis, dry eye, conjunctivitis, chronic superficial keratitis, corneal erosion, persistent corneal disorders, superficial punctate keratopathy, corneal epithelial defects, conjunctival epithelial defects, keratoconjunctivitis sicca, superior limbic keratoconjunctivitis, filamentary keratoconjunctivitis, infectious keratitis, noninfectious keratitis, infectious conjunctivitis and noninfectious conjunctivitis. The therapeutic agent is also useful as a therapeutic agent for corneal scarring and conjunctival scarring both associated with keratoconjunctive disorders. | 10-15-2015 |
20150209732 | CATION EXCHANGE MEMBRANCE AND METHOD FOR PRODUCING SAME - Provided is a cation exchange membrane having a stable ion exchange performance during usage, being excellent in basic properties such as membrane resistance and ion transportation as well as strength, and useful for electrodialysis and a method for producing the same. The cation exchange membrane is composed of a polyvinyl alcohol copolymer including an anionic group-containing anionic polymer segment and a vinyl alcohol polymer segment, and having a microphase separation structure having a domain size (X) in a range from 0 nm07-30-2015 | |
20150111769 | METHOD FOR ASSESSING ENDOMETRIAL CANCER SUSCEPTIBILITY - The present invention aims to provide an assessment method of corpus uteri cancer susceptibility, in which a human chromosomal region consisting of a nucleotide sequence of approximately 100 bps that exhibits a DNA copy number polymorphism associated with corpus uteri cancer susceptibility is identified and assessment is made based on an increase or decrease in the DNA copy number polymorphism. Corpus uteri cancer susceptibility can be assessed by: first, isolating a chromosomal region exhibiting the DNA copy number polymorphism specific for corpus uteri cancer by screening using a microarray derived from the peripheral blood, and subsequently, identifying DNA in a human chromosomal region consisting of a nucleotide sequence shown in any of SEQ ID NOs: 1 to 7, which is associated with corpus uteri cancer susceptibility, from a vast number of chromosomal regions including not only the chromosomal regions isolated by the above screening, but also regions not covered by the microarray, and then detecting a decrease in DNA copy number in the human chromosomal region consisting of the nucleotide sequence shown in any of SEQ ID NOs: 1 to 7. | 04-23-2015 |
20150031103 | NOVEL PROMOTER AND USE THEREOF - The promoter of the present invention causes a desired gene to be highly expressed, especially in thermotolerant yeast. The promoter is located upstream of the PIR1 gene or the CTR1 gene on the | 01-29-2015 |
20140275183 | AGENT FOR REDUCING SIDE EFFECTS OF KINASE INHIBITOR - The present invention relates to an agent for reducing the side effects of kinase inhibitors, the agent containing at least one branched-chain amino acid selected from among isoleucine, leucine and valine or a salt thereof as an active ingredient, and also relates to an anticancer medicine containing at least one branched-chain amino acid selected from among isoleucine, leucine and valine or a salt thereof, and a kinase inhibitor. | 09-18-2014 |
20140186853 | METHOD FOR ANALYZING MUCIN 1 USING PROBE CAPABLE OF BINDING TO 3'-SULFONATED CORE 1 CARBOHYDRATE CHAIN, AND METHOD FOR DETECTING OR MONITORING BREAST CANCER - The purpose of the present invention is to provide a method for detecting even mucin 1 derived from breast cancer, which cannot be detected by a CA15-3 measurement method. | 07-03-2014 |
20140183035 | SPUTTERING APPARATUS AND METHOD FOR FORMING THIN FILM - A sputtering method uses a sputtering apparatus for forming a thin film, the sputtering apparatus comprising a pair of facing polygonal prism target holders in which a target is placed on each surface parallel to a rotation axis of a rotatable polygonal prism body. A magnetic pole group including a plurality of magnets is disposed on a back surface of each of the targets, and each of the magnetic pole groups includes magnets or yokes of different magnetic pole directions. The magnets or yokes on the back surface of each of the targets are disposed so that adjacent magnets or yokes become alternately different magnetic pole direction, and the magnets or yokes disposed on the back surfaces of the targets have polarities opposite to each other. | 07-03-2014 |
20140179002 | TERMINATOR SEQUENCE-CONTAINING REVERSE PRIMER FOR OVEREXPRESSION AND LINEAR DNA - Plasmid vectors have been widely used as a carrier of a DNA sequence capable of expressing a target RNA in cells. However, construction of these plasmid vectors requires technical skill and time. Thus, a quicker and easier method is required therefor. To solve this problem, a method using a linear DNA that has been amplified by the PCR method is examined. However, this method is disadvantageous in that RNA expression in cells is extremely low. Under these circumstances, the present inventors attempted to develop an RNA expression method using a linear DNA which can be produced mainly by using the PCR method alone and which enables a high level of RNA expression. As the results of intensive studies on terminator sequences to be used in a linear DNA, the present inventors found a smallest unit of a terminator sequence enabling linear DNA expression equivalent to that when using a plasmid vector. A linear DNA including the aforesaid terminator sequence can be produced quickly and easily, and enables RNA expression at a higher level. The present invention has been completed based on these findings. | 06-26-2014 |
20140170733 | ALGAE CULTIVATION METHOD AND ALGAE CULTIVATION EQUIPMENT - As a simple and convenient method for promoting the proliferation of algae, a method for cultivating the algae while conducting a procedure S | 06-19-2014 |
20140165462 | PLANT CULTIVATION METHOD AND PLANT CULTIVATION EQUIPMENT - As a plant cultivation method by an artificial light irradiation which is convenient, highly energy efficient, and excellent in growth promoting effect, a plant cultivation method which promotes the plant growth by conducting a step S | 06-19-2014 |
20140131194 | SPUTTERING DEVICE FOR FORMING THIN FILM AND METHOD FOR MAKING THIN FILM - A device and a method of facing target sputtering are provided, which can easily change magnetic flux line patterns between facing targets, thereby enabling to conveniently perform a plurality of kinds of sputtering such as facing target sputtering with facing mode, facing target sputtering with mixed mode composed of facing mode and magnetron mode. Thus, the device and the method of facing target sputtering effective for each material is provided. The sputtering device for forming a thin film in which a pair of target holders | 05-15-2014 |
20130313567 | BASE SUBSTRATE, GALLIUM NITRIDE CRYSTAL MULTI-LAYER SUBSTRATE AND PRODUCTION PROCESS THEREFOR - A GaN crystal multi-layer substrate having surfaces with various crystal orientations formed on a sapphire base substrate, such as a substrate whose principal surface is a <11-20> plane which is the a-plane, a <1-100> plane which is the m-plane, or a <11-22> plane having a low threading dislocation density and high crystal quality of a GaN crystal, and a production process therefor. | 11-28-2013 |
20130298822 | SILICON MELT CONTACT MEMBER, PROCESS FOR PRODUCTION THEREOF, AND PROCESS FOR PRODUCTION OF CRYSTALLINE SILICON - Provided are a silicon melt contact member which is markedly improved in liquid repellency to a silicon melt, which can retain the liquid repellency permanently, and which is suitable for production of crystalline silicon; and a process for efficient production of crystalline silicon, particularly, spherical crystalline silicon having high crystallinity, by use of the silicon melt contact member. A silicon melt contact member having a porous sintered body layer present on its surface, preferably the sintered body layer being present on a substrate of a ceramic material such as aluminum nitride, wherein the porous sintered body layer consists essentially of silicon nitride, has a thickness of 10 to 500 μm, and has, dispersed therein, many pores preferably having an average equivalent circle diameter of 1 to 25 μm at a pore-occupying area ratio of 30 to 80%, the pores connecting to each other to form communicating holes having a depth of 5 μm or more. | 11-14-2013 |
20130210107 | HIGH-EXPRESSION PROMOTER DERIVED FROM KLUYVEROMYCES MARXIANUS - Provided is a novel high-expression promoter, namely a GAL1 promoter, derived from | 08-15-2013 |
20130210012 | METHOD FOR ASSESSING BREAST CANCER SUSCEPTIBILITY - The present invention aims to provide a method for determining breast cancer susceptibility, in which a DNA copy number polymorphism associated with breast cancer susceptibility is identified and determination is made based on an increase or decrease in the DNA copy number polymorphism. The present invention attempts to achieve this by performing microarray assay using the peripheral blood of sporadic breast cancer patients, identifying a DNA copy number polymorphism associated with breast cancer susceptibility in a chromosomal region, detecting the number of copies of the above DNA copy number polymorphism by quantitative PCR, and then determining breast cancer susceptibility based on an increase or decrease in the DNA copy number polymorphism. Furthermore, the precision of the determination of breast cancer susceptibility can be improved by detecting a DNA copy number polymorphism by the aforementioned quantitative PCR by selecting two or more chromosomal regions and then performing a discriminant analysis based on the results thus obtained. | 08-15-2013 |
20130199274 | LEAKAGE INSPECTION APPARATUS AND LEAKAGE INSPECTION METHOD - Provided are a leakage inspection apparatus and a leakage inspection method for inspecting the flow rate of leakage from a tested body disposed in a tested-body chamber | 08-08-2013 |
20130115612 | METHOD FOR ANALYZING MUCIN 1 HAVING SIAALPHA2-8SIAALPHA2-3GALBETA GLYCANS - The object of the present invention is to provide a clinical marker capable of distinguishing breast cancer from interstitial pneumonia; and a clinical marker for detecting malignancy or progress level of breast cancer, and for monitoring effects of the treatment of breast cancer. The object can be solved by a method for analyzing mucin 1 having Siaα2-8Siaα2-3Galβ-R, characterized by comprising the step of bringing a first probe specifically binding to a mucin 1 having Siaα2-8Siaα2-3Galβ-R into contact with a sample to be tested. | 05-09-2013 |
20130072776 | CEREBRAL LOCAL PORTION COOLING PROBE AND CEREBRAL FUNCTION MAPPING DEVICE - A cerebral local portion cooling probe is composed so that a handheld module includes a Peltier device and a coolant liquid circulating part arranged so as to contact with the Peltier device and wirings, conduits and a heat radiating part are connected to this handheld module. Circulation of coolant liquid and operation of the Peltier device are implemented by means of a control unit, then the tip end of the handheld module is caused to contact with a cerebral local portion to be cooled and a state of the cerebral local portion is monitored in accordance with responses to the cooling. A cerebral function mapping device comprises a mapping module in which a plurality of cooling modules are arranged, each cooling module including a Peltier device and a coolant liquid circulating part in a manner similar to that of the cerebral local portion cooling probe. | 03-21-2013 |
20130059389 | Method for Producing Kluyveromyces Marxianus Transformant - An object to be solved by the present invention is to provide, for example, a method for producing a | 03-07-2013 |
20130017348 | INVISIBLE ENCLOSUREAANM Sanada; AtsushiAACI YamaguchiAACO JPAAGP Sanada; Atsushi Yamaguchi JP - An invisible enclosure includes a cylindrical central enclosure having a cavity formed therein and an outer shell formed of homogenous materials, with an object in the cavity and the central enclosure itself being substantially invisible with an electromagnetic wave. The central enclosure is formed by laminating a large number of cylindrical layered films formed by radially laminating a plurality of materials having different permittivities. Effective values of respective permittivities of respective parts of the central enclosure are adjusted by adjusting permittivities and radial thicknesses of respective layers of the layered films along a radius value of the central enclosure. The radial element of a permittivity tensor is set to be a value sequentially increasing along a radius from the innermost circumference of the central enclosure to the outermost circumference thereof and is set to be a predetermined value smaller than the permittivity of the outer shell at the outermost circumference. | 01-17-2013 |
20130005041 | Agent for Improving Gene Transfer Efficiency to Mammalian Cells - Provided is an efficiency improving agent for gene transfer to mammalian cells, a method for improving efficiency of gene transfer to mammalian cells, and a method for transforming mammalian cells. The method is characterized in that tRNA is used in combination with a lipofection reagent. Preferably, the agent may be used so that the tRNA concentration in a lipofection solution falls within the range of 3 to 50 μg/mL, and the concentration in a culture is approximately 1/10. More preferably, tRNA and PEG may be used in combination with a lipofection reagent. According to the present invention, gene transfer to mammalian cells with high efficiency can be achieved. | 01-03-2013 |
20120285881 | MULTILAYERED CHARGE-MOSAIC MEMBRANE AND MANUFACTURING METHOD THEREFOR - There is provided a multilayered charge-mosaic membrane having a porous supporting layer (A), a porous intermediate layer (B) and a charge-mosaic layer (C), wherein the porous supporting layer (A), the porous intermediate layer (B) and the charge-mosaic layer (C) are located in this order; the porous supporting layer (A) and/or the porous intermediate layer (B) are made of a fiber layer containing hydrophilic fibers; a thickness of the porous intermediate layer (B) is 0.1 to 100 μm; a porosity of the porous supporting layer (A) is larger than a porosity of the porous intermediate layer (B); the cationic and/or the anionic polymers constituting the charge-mosaic layer (C) is a polyvinyl alcohol having an ionic group. Thus, there is provided a multilayered charge-mosaic membrane having a large salt permeation flux and excellent mechanical strength. | 11-15-2012 |
20120225817 | THERAPEUTIC AGENT FOR GASTROINTESTINAL DISEASE - The present invention provides a therapeutic agent and a prophylactic agent for a gastrointestinal disease. A peptide having an amino acid sequence represented by Ser-Ser-Ser-Arg or a pharmaceutically acceptable salt thereof promotes wound healing in a gastrointestinal mucosal tissue, and is therefore useful as a therapeutic agent or a prophylactic agent for a gastrointestinal disease. Further, when (a) a peptide having an amino acid sequence represented by Ser-Ser-Ser-Arg or a pharmaceutically acceptable salt thereof and (b) a peptide having an amino acid sequence represented by Phe-Gly-Leu-Met-NH | 09-06-2012 |
20120157707 | METHOD FOR PRODUCING ALCOHOL COMPOUND - Provided is a method for producing an alcohol compound, which enables the alcohol compound to be obtained at a high yield from an amide compound or amine compound. The method for producing an alcohol compound, which is characterized by comprising allowing an alcohol in a supercritical state to act on the amide compound or amine compound in the presence of a carboxylic acid derivative to obtain the alcohol compound. | 06-21-2012 |
20120149937 | METHOD FOR PRODUCING HYDROXYCARBOXYLIC ACID DERIVATIVE - To provide a method for the production of a hydroxycarboxylic acid derivative, by which a hydroxycarboxylic acid derivative, which can be reused in various applications, can be obtained from a polyamide at a high yield without consuming a large amount of energy. A method for the production of a hydroxycarboxylic acid derivative, which is characterized by including allowing an alcohol in a supercritical state to act on a polyamide in the presence of a carboxylic acid derivative to depolymerize the polyamide to obtain the hydroxycarboxylic acid derivative. | 06-14-2012 |
20120101158 | Surface Anesthetic Agent - Provided is an anesthetic agent which can exhibit an anesthetic effect rapidly when adhered on mucosal membranes, the skin or the like by means of application or the like in local anesthesia, particularly surface anesthesia. Prepared are: a fast-acting surface anesthetic agent containing lidocaine and ethyl paraaminobenzoate at a specific ratio; and a super fast-acting surface anesthetic agent containing lidocaine, ethyl paraaminobenzoate and adrenaline at a specific ratio. | 04-26-2012 |
20120034481 | CHARGE-MOSAIC MEMBRANE - There is provided a charge-mosaic membrane comprising a cationic block copolymer (P) having a vinyl alcohol polymer block (A) and a cationic-group containing polymer block (B) as components; and an anionic block copolymer (Q) having a vinyl alcohol polymer block (C) and an anionic-group containing polymer block (D) as components. Such a charge-mosaic membrane is useful as a charge-mosaic membrane for piezodialysis because it exhibits higher membrane strength and higher permselectivity and has a larger charge density and a larger salt permeation flux. | 02-09-2012 |
20120031834 | ION-EXCHANGE MEMBRANE AND METHOD FOR PRODUCING SAME - There is provided an ion-exchange membrane comprising an ion-exchange layer made of a cationic polymer and/or an anionic polymer and a supporting layer, wherein the ion-exchange layer is formed on the supporting layer by printing. Such an ion-exchange membrane exhibits excellent anti-organic fouling and low membrane resistance, thereby high efficient and long-time stable electrodialysis can be achieved. Formation of the ion-exchange layer as a charge-mosaic layer consisting of the cationic polymer domains and the anionic polymer domains provides a charge-mosaic membrane exhibiting excellent electrolyte permselectivity and mechanical strength. | 02-09-2012 |
20120009768 | METHOD FOR FORMING SAPPHIRE SUBSTRATE AND SEMICONDUCTOR DEVICE - In a semiconductor device fabricated by growing a compound semiconductor layer on a sapphire substrate, a sapphire substrate enabling the semiconductor device to have a high light-extraction efficiency is provided. | 01-12-2012 |
20120009480 | ELECTROLYTE SOLUTION FOR LITHIUM ION SECONDARY BATTERY, LITHIUM ION SECONDARY BATTERY, FLUOROALKANE DERIVATIVE AND GELLING AGENT - The electrolyte solution for a lithium ion secondary battery according to the present invention contains a nonaqueous solvent, a lithium salt and a compound represented by the general formula (Z) shown below. Thereby, a lithium ion secondary battery having high battery characteristics and simultaneously achieving a high safety as well can be provided. | 01-12-2012 |
20110288783 | SYSTEM FOR PREDICTING DRUG EFFECTS AND ADVERSE EFFECTS AND PROGRAM FOR THE SAME - A drug effect-adverse effect prediction system includes a clinical data analysis table generating part, for each combination of genotypes relating to a drug effect or adverse effect, for generation of an analysis table for handling cases related to presence or absence of the drug effect or adverse effect. The system also includes a reliability analysis part, a discrimination formula generating part, a prediction part, and a discrimination formula optimizing part. | 11-24-2011 |
20110213249 | ULTRASONIC DIAGNOSTIC APPARATUS - An ultrasonic diagnostic apparatus which can measure a time difference of motion between a plurality of sites of a cardiac muscle for the heart of a fetus is provided. On a tomographic image of the heart, a user sets a plurality of observation points. Each observation point is tracked, and a plurality of displacement waveforms representing a temporal displacement of the plurality of observation points are generated. A time difference between a plurality of representative points is calculated between the plurality of displacement waveforms. Such a time difference is displayed as a numerical value or as a graph. The representative point is a peak point, a zero-cross point, an inflection point, or the like. The plurality of observation points are set along conduction pathways in the heart for the electric signal. | 09-01-2011 |
20110191390 | CHEMICAL REACTION TRANSITION STATE SEARCH SYSTEM, CHEMICAL REACTION TRANSITION STATE SEARCH METHOD, AND CHEMICAL REACTION TRANSITION STATE SEARCH PROGRAM - A chemical reaction transition state search system includes an input device, an arithmetic processing unit, and a storage device in order to find a chemical structure being in a targeted transition state in a chemical reaction. The arithmetic processing unit includes an IG forming unit, a CG-search calculating unit, a TS optimization calculating unit, a reactive-site fixing unit, a substituent processing unit, and a structural optimization calculating unit. | 08-04-2011 |
20110106794 | Synthesis path evaluation system and method and program thereof - A synthetic route evaluation system extracts an optimal synthetic route from a plurality of synthetic routes for a target compound to be synthetically produced. The synthetic route evaluation system includes an arithmetic processing device, which is composed of a quantum chemistry calculation unit, a reaction mechanism analysis unit, and a synthetic route ranking unit, and a storage device for storing data relative to the synthetic routes. | 05-05-2011 |
20110065205 | METHOD FOR DETERMINING PROGNOSIS OF ACUTE CENTRAL NERVOUS SYSTEM DISORDER - The present invention has its main object of providing a method for determining prognosis scientifically by searching an early marker for predicting neurological prognosis in order to grasp the disease state of a patient with an acute central nervous system disorder in the early stage and enabling an appropriate treatment to be performed. The method for determining the prognosis is provided in which the expression level of SH3BGRL3 in the biological fluid of the patient within 48 hours after resuscitation from cardiopulmonary arrest is measured, and the prognosis of the disorder classified into a good prognosis group and a poor prognosis group depending on the expression level or the presence or absence of the expression based on the Glasgow Outcome Scale (GOS) is predicted. | 03-17-2011 |
20110053150 | Method and Kit for Detection/Quantification of Target RNA - [Object] It is to provide a method and a kit capable of detecting or quantifying a target RNA simply and rapidly from trace amounts of RNA in a sample, in a case such as when one or more kinds of pathogenic microorganisms are to be detected or quantified. | 03-03-2011 |
20110020937 | FLOCCULENT YEAST AND METHOD FOR PRODUCTION THEREOF - It is to provide a novel | 01-27-2011 |
20100285083 | DRUG DELIVERY SYSTEM - It is a main object of the present invention to provide a drug delivery system in which drugs can be changed or which can be recharged with drugs, which continuously delivers drugs at effective concentrations to local lesional sites in a body and allows the use of drugs for which it has thus far been difficult to achieve effective local concentrations for a variety of reasons and drugs which have been difficult to use due to adverse effects on tissues that are not sites of action. The present invention provides a drug delivery system comprising an indwelling medical device on which a biocompatible material having target molecules on its surface has been coated, and target-recognizing nanocarriers (e.g., bio-nanocapsules, liposomes, liposome preparations, and nanoparticles) in which drugs are encapsulated and which have target-recognizing molecules capable of specifically binding to the target molecules. | 11-11-2010 |
20100173223 | Graft Copolymer and Process for Producing the Same - A graft copolymer having a side chain graft-polymerized by atom transfer living radical polymerization (ATRP) on a main chain polymerized by organotellurium-mediated living radical polymerization (TERP), wherein the molecular weight distribution is such that Mw/Mn is 1.5 or less. The graft copolymer is also such that a main chain moiety mainly consisting of the main chain and a side chain moiety mainly consisting of the side chain have microphase-separated structures. The graft copolymer has a narrow molecular weight distribution and forms microphase-separated structures through self organization of hydrophobic and hydrophilic moieties. | 07-08-2010 |
20100118412 | THREE-DIMENSIONAL LEFT-HANDED METAMATERIAL - A three-dimensional left-handed metamaterial having a completely new constitution, which functions as a three-dimensional electromagnetic wave propagation medium and in which an equivalent permittivity and a permeability of the medium simultaneously take negative values. The three-dimensional left-handed metamaterial is structured such that cubic unit cells | 05-13-2010 |
20100072061 | SPUTTERING APPARATUS FOR FORMING THIN FILM - A sputtering apparatus for forming a thin film includes a pair of facing polygonal prism target holders in which a target is placed on each surface which is parallel to a rotation axis of a rotatable polygonal prism body. A magnetic pole group which includes either a plurality of magnets or a magnet and a yoke is disposed on a back surface of the target, and the magnetic pole group includes magnets or yokes of different magnetic pole directions. | 03-25-2010 |
20100062506 | THERMOTOLERANT ETHANOL-PRODUCING YEAST AND ETHANOL PRODUCTION METHOD UTILIZING THE SAME - The present invention provides a novel yeast strain capable of producing ethanol through fermentation with a high degree of efficiency at a temperature of 37° C. or higher, preferably a temperature ranging from 40 to 49° C. or higher, and also a method for producing ethanol by utilizing the yeast strain, and further, ethanol produced by the method. Therefore, in the present invention, an yeast strain (Deposit No. NITE BP-283, etc) belonging to species | 03-11-2010 |
20100033597 | IMAGE-PROCESSING UNIT, IMAGING APPARATUS, AND COMPUTER PROGRAM PRODUCT - An image-processing unit, comprising an exposure conversion circuit, a standard image-setting circuit, a contour extraction circuit, a contour comparison circuit, a final setting circuit, and an image synthesis circuit, is provided. The exposure conversion circuit generates first and second exposure level image data. The standard image-setting circuit sets standard image data. The contour extraction circuit extracts standard and first comparison contours on the basis of the standard image data. The contour comparison circuit detects a first accordance indicator on the basis of the contours. The final setting circuit sets the first conclusive threshold on the basis of the first accordance indicator. The image synthesis circuit generates the rendered image data based on the first conclusive threshold. | 02-11-2010 |
20100007436 | TWO-DIMENSIONAL LEFT-HANDED METAMATERIAL - The present invention provides a two-dimensional left-handed metamaterial that functions as a two-dimensional electromagnetic wave propagation medium in which the equivalent permittivity and permeability of the medium are both negative, exhibits superior low-loss, broadband characteristics as a left-handed material, and has a simple constitution, enabling low-cost manufacture. | 01-14-2010 |
20090281733 | METHOD FOR EVALUATING TREE PRODUCTION CAPACITY, IMAGE CAPTURE DEVICE FOR EVALUATING TREE PRODUCTION CAPACITY, AND PROGRAM FOR EVALUATING TREE PRODUCTION CAPACITY - Evaluation of tree production capacity by a non-destructive method using a tree crown structure measurement device or using an image capture device with a fisheye lens mounted, for isolated trees or for trees existing at intervals, is enabled without requiring a large amount of time. | 11-12-2009 |
20090174609 | STRIPLINE-TYPE COMPOSITE RIGHT/LEFT-HANDED TRANSMISSION LINE OR LEFT-HANDED TRANSMISSION LINE, AND ANTENNA THAT USES SAME - A stripline-type transmission line can easily change and control transmission characteristics by changing the permittivity of a substrate, and also provides an antenna that can extensively change and control the direction of radiation with the frequency of an electromagnetic wave constant, by using the transmission line. | 07-09-2009 |
20090124824 | PROCESS FOR PRODUCING 6-HYDROXYCAPROIC ESTER AND PROCESS FOR PRODUCING TRIALKYLAMINE - A process for producing a 6-hydroxycarpoic ester and a process for producing a trialkylamine in both of which nylon-6, ε-caprolactam, which is a monomer therefor, etc. are used as a raw material. The processes are intended to make nylon-6 wastes reusable in various applications without consuming a large quantity of energy. The process for producing a 6-hydroxycarpoic ester and process for producing a trialkylamine are characterized by reacting amide compounds basically comprising ε-caprolactam with an alcohol in a supercritical state to obtain a 6-hydroxycarpoic ester and a trialkylamine. | 05-14-2009 |